First, kudos to the article: "Strong evidence suggests that SARS-CoV-2 originated in horseshoe bats, but whether it passed directly from bats.. or.. an intermediate host, remains a mystery."
Scientific consensus is that bats are the ultimate source. But how did it get to Wuhan?
The Cambodian virus from 2010: "The virus’s genome has not yet been fully sequenced — nor its discovery published — making its full significance to the pandemic hard to ascertain."
Researchers told the reporter that in order to be more useful to the search for the pandemic origin, the Cambodian virus would need to share >97% of its genome with SARS-CoV-2.
BECAUSE the closest relative to SARS2 is RaTG13 batCoV collected by the WIV in 2013 from Yunnan China.
Similarly, the Japanese horseshoe bat virus Rc-o319 only shares 81% genome identity with SARS-CoV-2 "which makes it too distant to provide insights into the pandemic’s origin, says Edward Holmes, a virologist at the University of Sydney in Australia."
"The new virus would have to be at least 99% similar to SARS-CoV-2 to be an immediate ancestor of the current pandemic virus, says Irving (Aaron Irving, an infectious-diseases researcher at Zhejiang University in Hangzhou, China)."
People. I'm literally copying and pasting from the article. But I see members of the public going around saying that a 97% identical virus to SARS2 has been found in Cambodia or Japan.
This is making me feel like a good number of people don't read articles before sharing.
I'd also like to take this opportunity to raise an important point about global virus sampling efforts and anticipated outcomes. This article is talking a bat virus sample collected a decade ago in Cambodia - finally getting sequenced and being identified as a SARS-like virus...
Can we re-evaluate how global virus sampling is conducted around the world? How quickly these samples are processed, sequenced, shared publicly (or at least internationally on a restricted database)?
RaTG13 - 7 years, released post-covid
Cambodian virus - 10 years, post-covid
Is the current workflow truly expected to produce vaccines or therapeutics that will prepare us against future pandemics?
At the very least, if all natural pathogen sequences were shared on an internationally-hosted database, this would greatly expedite the ability to trace virus origins and whether lab activities (including sample collection from animals or remote human pops) pose outbreak risks.
I know @K_G_Andersen and I disagree on this point: Whether spillover from virus sampling counts as natural origins (Kristian's opinion) or lab-based scenario (imo). But I hope we can agree that identifying the activity that led to spillover is important to reducing risk.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Great article by @sciencecohen
"Not urgently needing the vaccines at home to fight a virus it has largely quashed, (China) is playing a global game.. using the vaccine to promote the diplomacy of foreign policy objectives." sciencemag.org/news/2020/11/g…
In-depth discussion of China vs the West's vaccine approaches: which can induce broader immunity, is easier to manufacture and distribute, has the risk of antibody-dependent enhancement of covid, and, importantly, can be readily manufactured locally in other countries...
"crucially for China’s vaccine diplomacy, many.. countries have manufacturers that have produced inactivated virus vaccines for decades.. (those) that cannot access vaccines bankrolled by Warp Speed—especially those that hosted China’s.. trials—might have a more secure vaccine.."
A lot of interest in the D614G mutation comes from whether it made SARS-CoV-2 significantly more challenging for other countries, including Europe and the US, to stop the spread of the virus compared to when it first emerged in China.
For instance, Malaysia's Health Ministry Director infamously said that the D614G variant is 10x more transmissible.
Even though D614G was also present in China in January. See thread:
Two peer-reviewed papers were just published discussing D614G and whether more transmissible variants of SARS-CoV-2 have emerged since late 2019: cell.com/cell/pdf/S0092…
Also people asking me about this @nytimes article about Dr. Limeng Yan, Steve Bannon & Miles Guo.
My stance has not changed. We need a way for whistleblowers to get out of China without Bannon and Guo standing in their way and damaging their credibility. nytimes.com/2020/11/20/bus…
My original thread response when Dr. Yan released her first preprint is here: "If there is one thing that this entire saga has made clear - it is that whistleblowers (as it pertains to SARS2) have no obvious safe route of sharing their information."
For those who aren't too familiar with Dr. Yan's story, here is a quick summary:
In Jan 2020, Yan was helping her supervisor to investigate the new covid outbreak. She heard rumors about the dangerous new virus that the Chinese gov was playing down, and blew the whistle...
How can scientists address questions that have been painted as conspiracy theories? And without amplifying or legitimizing misinformation related to these questions.
As a scientist who has been washed out to sea on a contentious covid topic, I find it safest to talk to science journalists for news articles - professionals with some extent of scientific training, who know what to ask scientists, how to probe their reasoning and evidence.
No way... of the 12 members of the Lancet origins investigation team, the chair (Daszak) and 5 other members (total of half the team) co-signed @TheLancet letter condemning lab origin conspiracy theories in early Feb. ecohealthalliance.org/2020/11/member…